{"disease":{"id":"nsclc-stage-i","name":"nsclc stage i"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06404164","title":"Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT05887011","title":"CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06788366","title":"AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04830826","title":"A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China","phase":"","overall_status":"COMPLETED","enrollment_count":1490,"lead_sponsor_name":"The First Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT03509779","title":"Pronostic and Predictive Value of EMT in Localized Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"European Georges Pompidou Hospital","has_results":false},{"nct_id":"NCT04633564","title":"MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":671,"lead_sponsor_name":"Mylan Pharmaceuticals Inc","has_results":true},{"nct_id":"NCT06028412","title":"Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":660,"lead_sponsor_name":"Xiaolong Yan, Dr.","has_results":false},{"nct_id":"NCT07005999","title":"Interventional Ablation for Early-stage Lung Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":656,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT06467383","title":"A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"MSD Italia S.r.l.","has_results":false},{"nct_id":"NCT05701787","title":"Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT07150598","title":"Immune-Marker Platform for Patients With Advanced Lung Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT06947694","title":"A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":427,"lead_sponsor_name":"Xinqiao Hospital of Chongqing","has_results":false},{"nct_id":"NCT06953843","title":"Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":366,"lead_sponsor_name":"Xinqiao Hospital of Chongqing","has_results":false},{"nct_id":"NCT07128199","title":"A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Taiho Oncology, Inc.","has_results":false},{"nct_id":"NCT06854939","title":"A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"National Cancer Center, Japan","has_results":false},{"nct_id":"NCT02864992","title":"Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":337,"lead_sponsor_name":"EMD Serono Research & Development Institute, Inc.","has_results":true},{"nct_id":"NCT04492969","title":"Prospective Observation of Failure Patterns in NSCLC Treated With ICIs","phase":"","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05014815","title":"Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"BeiGene","has_results":true},{"nct_id":"NCT04317534","title":"Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Greg Durm, MD","has_results":false},{"nct_id":"NCT05652868","title":"Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":227,"lead_sponsor_name":"Mythic Therapeutics","has_results":false},{"nct_id":"NCT04306094","title":"Factors Determining the Prognosis in NSCLC Stage IV","phase":"","overall_status":"UNKNOWN","enrollment_count":217,"lead_sponsor_name":"Instituto do Cancer do Estado de São Paulo","has_results":false},{"nct_id":"NCT07039656","title":"Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":211,"lead_sponsor_name":"Wen-zhao ZHONG","has_results":false},{"nct_id":"NCT04102982","title":"Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Shandong Provincial Hospital","has_results":false},{"nct_id":"NCT06829641","title":"Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05132218","title":"Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT03736993","title":"Metabolomics Predict Therapy Response","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Hasselt University","has_results":false},{"nct_id":"NCT04042558","title":"A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Centre Francois Baclesse","has_results":false},{"nct_id":"NCT07279402","title":"TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Antalya Training and Research Hospital","has_results":false},{"nct_id":"NCT06313541","title":"Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":146,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05344209","title":"Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":138,"lead_sponsor_name":"Vestre Viken Hospital Trust","has_results":false},{"nct_id":"NCT06114108","title":"Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT03341494","title":"EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":128,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06856798","title":"Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ziming Li","has_results":false},{"nct_id":"NCT04027647","title":"Phase 2 Study of Dacomitinib in NSCLC","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":118,"lead_sponsor_name":"National Cancer Centre, Singapore","has_results":false},{"nct_id":"NCT07120698","title":"Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false},{"nct_id":"NCT04745715","title":"Genomic Study in Non-small Cell Lung Cancer Brain Metastasis","phase":"","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT06234579","title":"Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)","phase":"","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03446547","title":"Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT05597800","title":"Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"Universita di Verona","has_results":false},{"nct_id":"NCT04136535","title":"Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":105,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06374160","title":"Exercise in Patients With Advanced Non-small Cell Lung Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT03454685","title":"The Role of Microbiota on the Development of Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Xiaorong Dong","has_results":false},{"nct_id":"NCT04392505","title":"Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT05311709","title":"Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Vestre Viken Hospital Trust","has_results":false},{"nct_id":"NCT04116918","title":"Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Baodong Qin","has_results":false},{"nct_id":"NCT03184571","title":"Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"BerGenBio ASA","has_results":true},{"nct_id":"NCT06339554","title":"Alectinib-induced Endocrine Toxicity","phase":"","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05543330","title":"A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Wuhan YZY Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT03705403","title":"IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":88,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT04768491","title":"Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC","phase":"","overall_status":"UNKNOWN","enrollment_count":82,"lead_sponsor_name":"Peking Union Medical College","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}